| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 01/03/2013 | US20130004520 Methods and materials related to hair pigmentation and cancer |
| 01/03/2013 | US20130004519 Smoci, tenascin-c and brain cancers |
| 01/03/2013 | US20130004518 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 01/03/2013 | US20130004517 Disc-1 pathway activators in the control of neurogenesis |
| 01/03/2013 | US20130004516 Drug for inflammatory bowel disease |
| 01/03/2013 | US20130004515 Methods for treating reperfusion injuries |
| 01/03/2013 | US20130004514 Therapeutic antibodies |
| 01/03/2013 | US20130004513 Agents for treating disease |
| 01/03/2013 | US20130004512 Nucleic acid molecules encoding bank1 splice variants |
| 01/03/2013 | US20130004511 Composition comprising inhibitors of irs-1 and of vegf |
| 01/03/2013 | US20130004510 Vaccine |
| 01/03/2013 | US20130004509 BRAF Mutations Conferring Resistance to BRAF Inhibitors |
| 01/03/2013 | US20130004508 Engineered anti-tslp antibody |
| 01/03/2013 | US20130004507 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 01/03/2013 | US20130004506 Method for treating pathologies associated with hypoxia using mif inhibitors |
| 01/03/2013 | US20130004505 Human monoclonal antibodies derived from human b cells and having neutralizing activity against influenza a viruses |
| 01/03/2013 | US20130004504 Method of modulating phenylalanine hydroxylase structure and function |
| 01/03/2013 | US20130004503 Engineered anti-tslp antibody |
| 01/03/2013 | US20130004502 Influenza targets |
| 01/03/2013 | US20130004501 Human il-23 antigen binding proteins |
| 01/03/2013 | US20130004500 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa |
| 01/03/2013 | US20130004499 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
| 01/03/2013 | US20130004498 Dosing for treatment with anti-egfl7 antibodies |
| 01/03/2013 | US20130004497 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 01/03/2013 | US20130004496 Monoclonal antibodies specific to hemagglutinin and neuraminidase from influenza virus h5-subtype or n1-subtype and uses thereof |
| 01/03/2013 | US20130004495 Anti-ngf antibodies for the treatment of various disorders |
| 01/03/2013 | US20130004494 Inhibition of P21 and Use Thereof for Inducing Tissue Regeneration |
| 01/03/2013 | US20130004493 Epithelial membrane protein-2 (emp2) and proliferative vitroretinopathy (pvr) |
| 01/03/2013 | US20130004492 Fgfr extracellular domain acidic region muteins |
| 01/03/2013 | US20130004491 Antibodies Against Phosphorylcholine In Combination Therapy with Biologic Agents |
| 01/03/2013 | US20130004490 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 01/03/2013 | US20130004489 Activin-actriia antagonists and uses for treating multiple myeloma |
| 01/03/2013 | US20130004488 Anti-cancer agent delivery vehicles capable of improved loading |
| 01/03/2013 | US20130004487 Scd40l and placental growth factor (pigf) as biochemical marker combinations in cardiovascular diseases |
| 01/03/2013 | US20130004486 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 01/03/2013 | US20130004485 Humanized and chimeric anti-properdin antibodies |
| 01/03/2013 | US20130004484 Anti-c-met antibody formulations |
| 01/03/2013 | US20130004483 Medical methods and agents for use therein |
| 01/03/2013 | US20130004482 Methods of Treating Breast Cancer with Anthracycline Therapy |
| 01/03/2013 | US20130004481 Anticancer therapy |
| 01/03/2013 | US20130004480 CD20 Binding Molecules for the Treatment of Copd |
| 01/03/2013 | US20130004458 Small Molecule Inhibitors of Retroviral Assembly and Maturation |
| 01/03/2013 | US20130004456 Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (gbm) and other cancers |
| 01/03/2013 | US20130004432 Monoclonal antibodies that bind b7h6 and uses thereof |
| 01/03/2013 | US20130004424 Methods for determining agents targeting mena isoforms and uses thereof for diagnosis and treatment of metastatic tumors |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | DE102011118022A1 Antikörper gegen das Prostata-spezifische Stammzellenantigen und dessen Verwendung Antibodies to the prostate specific antigen stem cells and the use thereof |
| 01/03/2013 | CA2840577A1 Soluble integrin .alpha.4 mutant |
| 01/03/2013 | CA2840335A1 Recombinant mistletoe lectin and use thereof as an adjuvant |
| 01/03/2013 | CA2840143A1 Composition comprising inhibitors of irs-1 and of vegf |
| 01/03/2013 | CA2839869A1 Anti-erbb3 antibobies in combination with paclitaxel for treatment of gynecological cancers |
| 01/03/2013 | CA2839832A1 Contiguous overlapping peptides for treatment of ragweed pollen allergy |
| 01/03/2013 | CA2839683A1 Therapeutic targeting of ficolin-3 |
| 01/03/2013 | CA2839668A1 Epitope and its use of hepatitis b virus surface antigen |
| 01/03/2013 | CA2839539A1 Heterodimerized polypeptide |
| 01/03/2013 | CA2839506A1 Canine coronavirus vaccine |
| 01/03/2013 | CA2839462A1 Inhibitors of t-cell activation |
| 01/03/2013 | CA2839387A1 An aqueous composition comprising a biological antigen and an acrylic acid polymer |
| 01/03/2013 | CA2835242A1 Anti-c-met antibody formulations |
| 01/02/2013 | EP2540828A1 Composition comprising inhibitors of IRS-1 and of VEGF |
| 01/02/2013 | EP2540827A1 Anti-icam3 antibody and use thereof |
| 01/02/2013 | EP2540744A1 Fully human monoclonal antibody to vegf, preparation method and use thereof |
| 01/02/2013 | EP2540743A1 Full human anti-tnf- alpha monoclonal antibody, preparation method and use thereof |
| 01/02/2013 | EP2540741A1 Humanized anti-CD22 antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
| 01/02/2013 | EP2540314A1 Raccoon poxvirus expressing rabies glycoproteins |
| 01/02/2013 | EP2540313A1 Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures |
| 01/02/2013 | EP2540312A1 Avian influenza chimeric VLPS |
| 01/02/2013 | EP2540311A1 Composite body for antigen or drug delivery |
| 01/02/2013 | EP2539369A1 Antagonist anti-il-7 receptor antibodies and methods |
| 01/02/2013 | EP2539368A1 Cancer vaccine |
| 01/02/2013 | EP2539365A2 Method of inducing the production of protective anti-hiv-1 antibodies |
| 01/02/2013 | EP2539360A1 Immunogenic proteins and compositions |
| 01/02/2013 | EP2539354A1 Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same |
| 01/02/2013 | EP2538975A2 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 01/02/2013 | EP2538974A1 Protein formulations |
| 01/02/2013 | EP2538973A2 Stable antibody containing compositions |
| 01/02/2013 | EP2538972A1 Recombinant cdv compositions and uses thereof |
| 01/02/2013 | EP2538971A1 Combination vaccine for streptococcus |
| 01/02/2013 | EP2538970A1 Treatment or prevention of infection |
| 01/02/2013 | EP2538969A1 Polysaccharide particle vaccines |
| 01/02/2013 | EP2538965A1 Therapeutic compositions for the treatment of dry eye disease |
| 01/02/2013 | CN1886148B Selective inhibition of NF-kB activation by peptides designed to disrupt NEMO oligomerization |
| 01/02/2013 | CN1854157B Antibodies to insulin-like growth factor i receptor |
| 01/02/2013 | CN1674934B Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 01/02/2013 | CN1671416B Super humanized antibodies |
| 01/02/2013 | CN1658899B Modified CEA nucleic acid and expression vectors |
| 01/02/2013 | CN1551781B One dose vaccination with mycoplasma hyopneumoniae |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102859360A Prognostic marker for cryoglobulinemic vasculitis and B cell malignancies in HCV infected patients |
| 01/02/2013 | CN102858977A Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858976A Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858975A Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858974A Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858964A Polypeptides |
| 01/02/2013 | CN102858963A Anti-trypanosomiasis vaccines and diagnostics |
| 01/02/2013 | CN102858961A Novel method |
| 01/02/2013 | CN102858960A Plasmids and methods for peptide display and affinity-selection on virus-like particles of rna bacteriophages |
| 01/02/2013 | CN102858804A Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/02/2013 | CN102858803A Neutralizing prolactin receptor antibodies and their therapeutic use |
| 01/02/2013 | CN102858802A Human antigen binding proteins that bind beta-KLOTHO, FGF receptors and complexes thereof |